The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer
Open Access
- 1 August 2012
- journal article
- Published by Springer Science and Business Media LLC in Radiation Oncology
- Vol. 7 (1), 127
- https://doi.org/10.1186/1748-717x-7-127
Abstract
To evaluate the influence of the maximum involvement of biopsy core (MIBC) on outcome for prostate cancer patients treated with dose-escalated external beam radiotherapy (EBRT). The outcomes of 590 men with localized prostate cancer treated with EBRT (≥75 Gy) at a single institution were retrospectively analyzed. The influence of MIBC on freedom from biochemical failure (FFBF), freedom from metastasis (FFM), cause-specific survival (CSS), and overall survival (OS) was compared to other surrogates for biopsy tumor volume, including the percentage of positive biopsy cores (PPC) and the total percentage of cancer volume (PCV). MIBC correlated with PSA, T-stage, Gleason score, NCCN risk group, PPC, PCV, and treatment related factors. On univariate analysis, MIBC was prognostic for all endpoints except OS; with greatest impact in those with Gleason scores of 8–10. However, on multivariate analysis, MIBC was only prognostic for FFBF (hazard ratio [HR] 1.9, p = 0.008), but not for FFM (p = 0.19), CSS (p = 0.16), and OS (p = 0.99). In patients undergoing dose-escalated EBRT, MIBC had the greatest influence in those with Gleason scores of 8–10 but provided no additional prognostic data as compared to PPC and PCV, which remain the preferable prognostic variables in this patient population.Keywords
This publication has 11 references indexed in Scilit:
- Percentage of Cancer Volume in Biopsy Cores Is Prognostic for Prostate Cancer Death and Overall Survival in Patients Treated With Dose-Escalated External Beam RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Percentage of Positive Biopsy Cores: A Better Risk Stratification Model for Prostate Cancer?International Journal of Radiation Oncology*Biology*Physics, 2011
- The Percent of Positive Biopsy Cores Improves Prediction of Prostate Cancer–Specific Death in Patients Treated With Dose-Escalated RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Prognostic value of various morphometric measurements of tumour extent in prostate needle core tissueHistopathology, 2008
- Interval to Biochemical Failure Highly Prognostic for Distant Metastasis and Prostate Cancer-Specific Mortality After RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Percent Positive Biopsy Cores as a Prognostic Factor for Prostate Cancer Treated with External Beam RadiationUrology, 2007
- Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- NCCN Practice Guidelines for Prostate Cancer.2000
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998